Ian F. Smith
2019
In 2019, Ian F. Smith earned a total compensation of $1.5M as Former EVP & Chief Operating Officer and Former Interim Chief Financial Officer at Vertex Pharmaceuticals, a 69% decrease compared to previous year.
Compensation breakdown
| Salary | $75,192 |
|---|---|
| Other | $1,376,648 |
| Total | $1,451,840 |
Smith received $1.4M in other compensation, accounting for 95% of the total pay in 2019.
Smith also received $75.2K in salary.
Rankings
In 2019, Ian F. Smith's compensation ranked 7,462nd out of 13,971 executives tracked by ExecPay. In other words, Smith earned more than 46.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,462 out of 13,971 | 47th |
Division Manufacturing | 2,891 out of 5,692 | 49th |
Major group Chemicals And Allied Products | 1,083 out of 2,189 | 51st |
Industry group Drugs | 923 out of 1,875 | 51st |
Industry Pharmaceutical Preparations | 680 out of 1,387 | 51st |
Source: SEC filing on April 28, 2020.
Smith's colleagues
We found six more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2019.
2019
Jeffrey Leiden
Vertex Pharmaceuticals
Chairman
2019
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2019
Reshma Kewalramani
Vertex Pharmaceuticals
Chief Executive Officer
2019
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Patient Officer
2019
Charles Wagner
Vertex Pharmaceuticals
Chief Financial Officer
2019
Paul Silva
Vertex Pharmaceuticals